Principal Display Panel (Maintenance Kit Carton)
Abilify Mycite
Product Images NDC 59148-032
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Abilify Mycite (NDC 59148-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Otsuka America Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (Starter Kit Carton)
Principal Display Panel (Maintenance Kit Carton)
Principal Display Panel (Starter Kit Carton)
Abilify MyCite is a medication consisting of aripiprazole tablets with a sensor. It comes with a 30-Day Starter Kit and is intended to be dispensed with a Medication Guide for patients. A compatible mobile device is required for use. It should be kept out of reach of children and its components should be kept away from moisture, heat, and light. Crushing or chewing the tablets is not recommended. There is additional text present which appears to be random characters with no meaning.*
Principal Display Panel (Maintenance Kit Carton)
Principal Display Panel (Starter Kit Carton)
Principal Display Panel (Maintenance Kit Carton)
Principal Display Panel (Starter Kit Carton)
Principal Display Panel (Maintenance Kit Carton)
Principal Display Panel (Starter Kit Carton)
Principal Display Panel (Maintenance Kit Carton)
Principal Display Panel (Starter Kit Carton)
Chemical Structure (Mycite Chem Structure)
Figure 1 (Mycite Figure 01)
This text provides information about the effect of different drugs on Aripiprazole tablets. The drugs are categorized based on their impact on CYP enzymes and their inhibition or induction effect. The drugs discussed include CYP3A4 inhibitor ketoconazole, CYP2D6 inhibitor quinidine, CYP3A4 inducer carbamazepine, gastric acid blockers like famotidine, and other drugs like valproate and lorazepam. The text also presents the fold change and 90% confidence interval for Aripiprazole with and without interacting drugs in multiples of the reference value.*
Figure 2 (Mycite Figure 02)
This text appears to be a table describing the effect of various drugs on the absorption and metabolism of a medication called Aripiprazole. The drugs listed include inhibitors and inducers of enzymes that affect Aripiprazole's metabolism, as well as gastric acid blockers and other medications such as valproate and lorazepam. The table also includes measurements of the impact each drug has on the amount and rate of absorption of Aripiprazole. However, without additional context, it is not possible to provide a more detailed description of the information in this table.*
Figure 3 (Mycite Figure 03)
Figure 4 (Mycite Figure 04)
This appears to be a table or chart discussing the effects of certain factors on the pharmacokinetics of a drug called Aripiprazole. The factors include genetics (with a reference to cYp206 and extensive metabolizers), gender, age, and the presence of hepatic or renal impairment. The chart also includes fold change and 90% confidence intervals for Aripiprazole.*
Figure 5 (Mycite Figure 05)
This appears to be a chart or table concerning the effects of various factors on drug metabolism and absorption in different populations. The factors considered include CYP2D6 metabolizer status, gender, age, and hepatic and renal impairment. The table lists the effects on various pharmacokinetic parameters such as AUC and Cmax, and also includes data on Dehydro-Aripiprazole Fold Change and 90% CI.*
Figure 6 (Mycite Figure 06)
This is a statistical report showing proportions of patients with relapse, using aripiprazole and placebo, at different time intervals after randomization. The number of subjects at risk is shown for each interval.*
Figure 7 (Mycite Figure 07)
Figure 8 (Mycite Figure 08)
Figure 9 (Mycite Figure 09)
Figure 10 (Mycite Figure 10)
Figure 10 (Mycite Figure 11)
Image (Mycite Figure 12)
Image (Mycite Figure 13)
Image (Mycite Figure 14)
Image (Mycite Figure 15)
Image (Mycite Figure 15a)
Image (Mycite Figure 15b)
Image (Mycite Figure 15c)
Image (Mycite Figure 15d)
Image (Mycite Figure 16)
Image (Mycite Figure 17)
This is a set of instructions for using a patch. It includes steps for opening a pod and strip, pairing the patch, and applying it. No further information is available.*
Image (Mycite Figure 18)
Image (Mycite Figure 19)
Image (Mycite Figure 19a)
Image (Mycite Figure 19b)
The given text can be used as a simple instruction to gently clean an area by using soap and water.*
Image (Mycite Figure 20)
Image (Mycite Figure 21)
This text appears to be a set of instructions regarding the preparation, pairing, and application of a patch. Without further context or specific information, it is difficult to provide a more detailed description.*
Image (Mycite Figure 22)
This text provides instructions on preparing, pairing, and applying a patch, but does not give any specific details or context beyond those basic steps. It appears to be part of a larger set of instructions or a guide, but without additional information, it is not possible to determine the specific product or purpose for which these instructions apply.*
Image (Mycite Figure 23)
Image (Mycite Figure 23a)
Image (Mycite Figure 23b)
Image (Mycite Figure 23c)
Image (Mycite Figure 23d)
Image (Mycite Figure 24)
Image (Mycite Figure 25)
This appears to be a set of instructions for using a skincare product that involves opening a pod and strip and applying a patch. The instructions also suggest preparing the skin before use.*
Image (Mycite Figure 26)
This text appears to be a set of instructions for using a skincare product. The instructions involve preparing one's skin, opening a pod and strip, pairing a patch and applying the patch. Further context or details about the product are not available.*
Image (Mycite Figure 27)
Image (Mycite Figure 27a)
Image (Mycite Figure 27b)
Image (Mycite Figure 27c)
Image (Mycite Figure 27d)
Image (Mycite Figure 28)
Image (Mycite Figure 29)
Image (Mycite Figure 30)
This text appears to be a set of instructions for using a skincare product. The instructions cover how to prepare your skin, open the product packaging, pair the patch with the product, and apply it to the skin.*
Image (Mycite Figure 31)
Image (Mycite Figure 31a)
Image (Mycite Figure 31b)
Image (Mycite Figure 31c)
Image (Mycite Figure 31d)
Image (Mycite Figure 32)
Image (Mycite Figure 33)
Image (Mycite Figure 34)
Image (Mycite Figure 35)
Not available.*
Image (Mycite Figure 35a)
Image (Mycite Figure 35b)
Image (Mycite Figure 35c)
Image (Mycite Figure 35d)
Image (Mycite Figure 35e)
Image (Mycite Figure 36)
Image (Mycite Figure 37)
Image (Mycite Figure 38)
Image (Mycite Figure 39)
Image (Mycite Figure 39a)
Image (Mycite Figure 39b)
Image (Mycite Figure 39c)
Image (Mycite Figure 39d)
Image (Mycite Figure 39e)
The text is not readable.*
Image (Mycite Figure 39f)
Image (Mycite Figure 39g)
Image (Mycite Figure 39h)
Image (Mycite Figure 39i)
Image (Mycite Figure 39j)
Image (Mycite Figure 39k)
Image (Mycite Figure 40)
Image (Mycite Figure 41)
Image (Mycite Figure 42)
Image (Mycite Figure 43)
Image (Mycite Figure 43a)
Image (Mycite Figure 43b)
The text seems to be an incomplete sentence and does not provide any useful information or context. Therefore, the description cannot be generated.*
Image (Mycite Figure 43c)
Image (Mycite Figure 43d)
Image (Mycite Figure 44)
Image (Mycite Figure 45)
Image (Mycite Figure 46)
Image (Mycite Figure 47)
Image (Mycite Figure 47a)
Image (Mycite Figure 47b)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
